Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
2101829-58-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
HIS-M535-100ug 100 µg
Monoclonal Anti-His Tag Antibody, Human IgG1 (AY63) (MALS verified)
Ask
View Details 
13727151 3x1.0μg DNA
C11orf89 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Ask
View Details 
MBS9010936 Inquire
Rabbit anti-Solanum tuberosum (Potato) 2MBCD Polyclonal Antibody
Ask
View Details 